Literature DB >> 1314486

Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes.

T R Billiar1, R D Curran, B G Harbrecht, J Stadler, D L Williams, J B Ochoa, M Di Silvio, R L Simmons, S A Murray.   

Abstract

Hepatocytes are known to synthesize nitric oxide (NO) from L-arginine via an inducible NO synthase. Studies were performed to determine the relationship between hepatocyte NO production and the stimulation of hepatocyte soluble guanylate cyclase. A combination of lipopolysaccharide (LPS), interferon-gamma, tumor necrosis factor, and interleukin-1 stimulates the biosynthesis of large quantities of nitrite and nitrate (NO2- + NO3-). Hepatocyte NO2- + NO3- production was associated with only small increases in intracellular guanosine 3',5'-cyclic monophosphate (cGMP) levels but much greater increases in extracellular cGMP release over an 18-h time period. This cGMP synthesis was dependent on the L-arginine concentration and was inhibited in a reversible manner by NG-monomethyl-L-arginine. The cytokines or LPS added alone induced small increases in nitrogen oxide production and concomitant minor elevations in cGMP release. Atrial natriuretic peptide also stimulated the release of cGMP by hepatocytes which appeared to be independent of the cytokine+LPS-induced cGMP release. The addition of probenecid reduced the cGMP release by 66%, while cell damage was excluded as a cause for the extracellular release. Addition of 3-isobutyl-1-methylxanthine, but not M&B 22948, increased hepatocyte intra- and extracellular cGMP levels after cytokine+LPS stimulation. Induction of nitrogen oxide synthesis by hepatocytes in vivo by injecting rats with killed Corynebacterium parvum resulted in increased cGMP levels in freshly isolated hepatocytes and increased cGMP release by the hepatocytes when placed in culture.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314486     DOI: 10.1152/ajpcell.1992.262.4.C1077

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse.

Authors:  D D Rees; F Q Cunha; J Assreuy; A G Herman; S Moncada
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

2.  Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

Authors:  J C López-Talavera; A Levitzki; M Martínez; A Gazit; R Esteban; J Guardia
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Induction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta.

Authors:  V Martin; A L Kleschyov; J P Klein; A Beretz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation.

Authors:  O Goureau; M Lepoivre; F Becquet; Y Courtois
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes.

Authors:  P A Bécherel; M D Mossalayi; F Ouaaz; L Le Goff; B Dugas; N Paul-Eugène; C Frances; O Chosidow; E Kilchherr; J J Guillosson
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 6.  Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.

Authors:  Satish Cheepala; Jean-Sebastien Hulot; Jessica A Morgan; Yassine Sassi; Weiqiang Zhang; Anjaparavanda P Naren; John D Schuetz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-16       Impact factor: 13.820

7.  Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart.

Authors:  Peter Dazert; Konrad Meissner; Silke Vogelgesang; Björn Heydrich; Lothar Eckel; Michael Böhm; Rolf Warzok; Reinhold Kerb; Ulrich Brinkmann; Elke Schaeffeler; Matthias Schwab; Ingolf Cascorbi; Gabriele Jedlitschky; Heyo K Kroemer
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  3':5'-cyclic guanosine monophosphate (cGMP) potentiates the inositol 1,4,5-trisphosphate-evoked Ca2+ release in guinea-pig hepatocytes.

Authors:  G Guihard; L Combettes; T Capiod
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 9.  Role of ischemic preconditioning in liver surgery and hepatic transplantation.

Authors:  Eduardo E Montalvo-Jave; Enrique Piña; Cesar Montalvo-Arenas; Raúl Urrutia; Luis Benavente-Chenhalls; Julieta Peña-Sanchez; David A Geller
Journal:  J Gastrointest Surg       Date:  2009-04-30       Impact factor: 3.452

10.  Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes.

Authors:  S Immenschuh; V Hinke; A Ohlmann; S Gifhorn-Katz; N Katz; K Jungermann; T Kietzmann
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.